REPORT ID 6616

EMEA (Europe, Middle East and Africa) Mono Vaccine Market Report 2017

Publish Date
26-Dec-17
Pages
100
Format
Electronic (PDF)

In this report, the EMEA Mono Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Units), revenue (Million USD), market share and growth rate of Mono Vaccine for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Mono Vaccine market competition by top manufacturers/players, with Mono Vaccine sales volume (Units), price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    GSK
    Sanofi Pasteur
    Merck
    Pfizer
    CNBG
    Sanofi Pasteur MSD
    Serum Institute of India
    Biokangtai

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Meningococcal Vaccine
    Japanese Encephalitis Vaccine
    Yellow Fever Vaccine
    Hepatitis Vaccine
    Cholera Vaccine
    Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Adults
    Children

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Mono Vaccine Market Report 2017
1 Mono Vaccine Overview
    1.1 Product Overview and Scope of Mono Vaccine
    1.2 Classification of Mono Vaccine
        1.2.1 EMEA Mono Vaccine Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Mono Vaccine Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Meningococcal Vaccine
        1.2.4 Japanese Encephalitis Vaccine
        1.2.5 Yellow Fever Vaccine
        1.2.6 Hepatitis Vaccine
        1.2.7 Cholera Vaccine
        1.2.8 Other
    1.3 EMEA Mono Vaccine Market by Application/End Users
        1.3.1 EMEA Mono Vaccine Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Adults
        1.3.3 Children
    1.4 EMEA Mono Vaccine Market by Region
        1.4.1 EMEA Mono Vaccine Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Mono Vaccine (2012-2022)
        1.5.1 EMEA Mono Vaccine Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Mono Vaccine Revenue and Growth Rate (2012-2022)

2 EMEA Mono Vaccine Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Mono Vaccine Market Competition by Players/Manufacturers
        2.1.1 EMEA Mono Vaccine Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Mono Vaccine Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Mono Vaccine Sale Price by Players (2012-2017)
    2.2 EMEA Mono Vaccine (Volume and Value) by Type/Product Category
        2.2.1 EMEA Mono Vaccine Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Mono Vaccine Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Mono Vaccine Sale Price by Type (2012-2017)
    2.3 EMEA Mono Vaccine (Volume) by Application
    2.4 EMEA Mono Vaccine (Volume and Value) by Region
        2.4.1 EMEA Mono Vaccine Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Mono Vaccine Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Mono Vaccine Sales Price by Region (2012-2017)

3 Europe Mono Vaccine (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Mono Vaccine Sales and Value (2012-2017)
        3.1.1 Europe Mono Vaccine Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Mono Vaccine Revenue and Growth Rate (2012-2017)
    3.2 Europe Mono Vaccine Sales and Market Share by Type
    3.3 Europe Mono Vaccine Sales and Market Share by Application
    3.4 Europe Mono Vaccine Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Mono Vaccine Sales Volume by Countries (2012-2017)
        3.4.2 Europe Mono Vaccine Revenue by Countries (2012-2017)
        3.4.3 Germany Mono Vaccine Sales and Growth Rate (2012-2017)
        3.4.4 France Mono Vaccine Sales and Growth Rate (2012-2017)
        3.4.5 UK Mono Vaccine Sales and Growth Rate (2012-2017)
        3.4.6 Russia Mono Vaccine Sales and Growth Rate (2012-2017)
        3.4.7 Italy Mono Vaccine Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Mono Vaccine Sales and Growth Rate (2012-2017)

4 Middle East Mono Vaccine (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Mono Vaccine Sales and Value (2012-2017)
        4.1.1 Middle East Mono Vaccine Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Mono Vaccine Revenue and Growth Rate (2012-2017)
    4.2 Middle East Mono Vaccine Sales and Market Share by Type
    4.3 Middle East Mono Vaccine Sales and Market Share by Application
    4.4 Middle East Mono Vaccine Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Mono Vaccine Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Mono Vaccine Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Mono Vaccine Sales and Growth Rate (2012-2017)
        4.4.4 Israel Mono Vaccine Sales and Growth Rate (2012-2017)
        4.4.5 UAE Mono Vaccine Sales and Growth Rate (2012-2017)
        4.4.6 Iran Mono Vaccine Sales and Growth Rate (2012-2017)

5 Africa Mono Vaccine (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Mono Vaccine Sales and Value (2012-2017)
        5.1.1 Africa Mono Vaccine Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Mono Vaccine Revenue and Growth Rate (2012-2017)
    5.2 Africa Mono Vaccine Sales and Market Share by Type
    5.3 Africa Mono Vaccine Sales and Market Share by Application
    5.4 Africa Mono Vaccine Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Mono Vaccine Sales Volume by Countries (2012-2017)
        5.4.2 Africa Mono Vaccine Revenue by Countries (2012-2017)
        5.4.3 South Africa Mono Vaccine Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Mono Vaccine Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Mono Vaccine Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Mono Vaccine Sales and Growth Rate (2012-2017)

6 EMEA Mono Vaccine Manufacturers/Players Profiles and Sales Data
    6.1 GSK
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Mono Vaccine Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 GSK Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Sanofi Pasteur
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Mono Vaccine Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Sanofi Pasteur Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Merck
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Mono Vaccine Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Merck Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Pfizer
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Mono Vaccine Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Pfizer Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 CNBG
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Mono Vaccine Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 CNBG Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Sanofi Pasteur MSD
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Mono Vaccine Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sanofi Pasteur MSD Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Serum Institute of India
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Mono Vaccine Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Serum Institute of India Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Biokangtai
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Mono Vaccine Product Type, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Biokangtai Mono Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview

7 Mono Vaccine Manufacturing Cost Analysis
    7.1 Mono Vaccine Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Mono Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Mono Vaccine Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Mono Vaccine Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Mono Vaccine Market Forecast (2017-2022)
    11.1 EMEA Mono Vaccine Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Mono Vaccine Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Mono Vaccine Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Mono Vaccine Price and Trend Forecast (2017-2022)
    11.2 EMEA Mono Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Mono Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Mono Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Mono Vaccine Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Mono Vaccine Sales Forecast by Type (2017-2022)
    11.7 EMEA Mono Vaccine Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer